Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05081128 · ClinicalTrials.gov registry record · NA
Efficacy in iNPH Shunting (PENS) Trial
A NA study of Idiopathic Normal Pressure Hydrocephalus (INPH), sponsored by Johns Hopkins University.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 17
- Study locations
NCT05081128 is a NA study of Idiopathic Normal Pressure Hydrocephalus (INPH) that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 100 participants. The trial reports 17 study locations across 13 states.
The verdict
NCT05081128, a NA study of Idiopathic Normal Pressure Hydrocephalus (INPH), is active but no longer recruiting, sponsored by Johns Hopkins University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 17
- Study locations
Study Summary
The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.
Conditions Studied
Interventions
- DEVICE programmable CSF shunt valve
Study Locations (17)
California
- University of California, Davis - Davis
- University of Southern California - Los Angeles
- Pacific Neuroscience Institute - Santa Monica
New York
- New York University Langone Health - New York
- Mount Sinai Health System - New York
Other
- University of British Columbia - Vancouver
- Umeå University - Umeå
Florida
- University of South Florida - Tampa
Georgia
- Emory University - Atlanta
Indiana
- Indiana University - Indianapolis
Maryland
- Johns Hopkins University - Baltimore
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2022-05-18 |
| Est. Completion | 2027-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05081128
The ClinicalTrials.gov registry entry for NCT05081128 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Idiopathic Normal Pressure Hydrocephalus (INPH) appearing as the primary indexed condition, and to 1 intervention - of which programmable CSF shunt valve is the first listed.
NCT05081128 reports 17 study locations spanning 13 distinct geographic areas - top geographies include California, New York, Other.
Frequently Asked Questions
What is clinical trial NCT05081128 about?
NCT05081128 is a clinical study titled "Efficacy in iNPH Shunting (PENS) Trial". The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigation of cerebrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.
What is the current status of trial NCT05081128?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-05-18. Estimated completion is 2027-08.
What conditions does trial NCT05081128 study?
This clinical trial studies the following conditions: Idiopathic Normal Pressure Hydrocephalus (INPH).
What interventions are being tested in trial NCT05081128?
The interventions under investigation include: programmable CSF shunt valve (DEVICE).
Who is sponsoring clinical trial NCT05081128?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05081128 being conducted?
This trial has 17 study locations across California, Florida, Georgia, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.